Literature DB >> 18346058

Prevalence of chronic pain in a representative sample in the United States.

Jochen Hardt1, Clemma Jacobsen, Jack Goldberg, Ralf Nickel, Dedra Buchwald.   

Abstract

OBJECTIVE: Chronic pain is a common reason for seeking medical care. We estimated the prevalence of chronic regional and widespread pain in the United States population overall, and by age, sex, and race/ethnicity.
SETTING: We examined the data from 10,291 respondents who participated in the 1999-2002 NHANES (National Health and Nutrition Examination Survey) and completed a pain questionnaire. Items allowed classification of chronic (>or=3 months) pain as regional or widespread. We used regression models to test the association of sex and race/ethnicity with each pain outcome, adjusting for age.
RESULTS: Chronic pain prevalence estimates were 10.1% for back pain, 7.1% for pain in the legs/feet, 4.1% for pain in the arms/hands, and 3.5% for headache. Chronic regional and widespread pain were reported by 11.0% and 3.6% of respondents, respectively. Women had higher odds than men for headache, abdominal pain, and chronic widespread pain. Mexican-Americans had lower odds compared with non-Hispanic whites and blacks for chronic back pain, legs/feet pain, arms/hands pain, and regional and widespread pain.
CONCLUSION: The population prevalence of chronic pain in the United States was lower than previously reported, with smaller sex-related differences and some variation by race/ethnicity.

Entities:  

Mesh:

Year:  2008        PMID: 18346058     DOI: 10.1111/j.1526-4637.2008.00425.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  88 in total

1.  Temporomandibular joint and muscle disorder-type pain and comorbid pains in a national US sample.

Authors:  Octavia Plesh; Sally H Adams; Stuart A Gansky
Journal:  J Orofac Pain       Date:  2011

2.  Chronic pain, overweight, and obesity: findings from a community-based twin registry.

Authors:  Lisa Johnson Wright; Ellen Schur; Carolyn Noonan; Sandra Ahumada; Dedra Buchwald; Niloofar Afari
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

3.  Yoga and other meditative movement therapies to reduce chronic pain.

Authors:  Allison Achilefu; Kunal Joshi; Megan Meier; Laine H McCarthy
Journal:  J Okla State Med Assoc       Date:  2017-01

Review 4.  Chronic pain disorders and headache chronification.

Authors:  Thomas McFate; Ann I Scher
Journal:  Curr Pain Headache Rep       Date:  2009-08

5.  Calcium channel α2δ1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis.

Authors:  Kang-Wu Li; Yanhui Peter Yu; Chunyi Zhou; Doo-Sik Kim; Bin Lin; Kelli Sharp; Oswald Steward; Z David Luo
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

Review 6.  Descending pain modulation and chronification of pain.

Authors:  Michael H Ossipov; Kozo Morimura; Frank Porreca
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

Review 7.  Using Screening Tests to Predict Aberrant Use of Opioids in Chronic Pain Patients: Caveat Emptor.

Authors:  Robert W Bailey; Kevin E Vowles
Journal:  J Pain       Date:  2017-06-29       Impact factor: 5.820

8.  Development and implementation of a telehealth-enhanced intervention for pain and symptom management.

Authors:  Linda H Eaton; Debra B Gordon; Sheryl Wyant; Brian R Theodore; Alexa R Meins; Tessa Rue; Cara Towle; David Tauben; Ardith Z Doorenbos
Journal:  Contemp Clin Trials       Date:  2014-05-17       Impact factor: 2.226

Review 9.  Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics.

Authors:  Teresa D Schmidt; J David Haddox; Alexandra E Nielsen; Wayne Wakeland; John Fitzgerald
Journal:  J Behav Health Serv Res       Date:  2015-10       Impact factor: 1.505

10.  Pain among older Hispanics in the United States: is acculturation associated with pain?

Authors:  Nathalia Jimenez; Elizabeth Dansie; Dedra Buchwald; Jack Goldberg
Journal:  Pain Med       Date:  2013-05-29       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.